Breaking News Instant updates and real-time market news.

2022-05-23 07:35:20 RNGTF Osisko Development $3.26 / + (+0.00%) , ODV Osisko Development / + 07:35 05/23/22 05/23 07:35 05/23/22 07:35	Osisko Development to commence trading on New York Stock Exchange Osisko Development is pleased to announce that it has been approved to list its common shares on the New York Stock Exchange. The Common Shares are expected to commence trading on the NYSE on May 27, 2022 under the trading ticker symbol "ODV". Osisko Development will retain its listing on the TSX Venture Exchange under the symbol "ODV". Upon the Common Shares commencing trading on the NYSE, the escrow release condition relating to the subscription receipts of the Corporation issued on March 4, 2022, March 29, 2022 and April 21, 2022 will be satisfied. Upon the satisfaction of such escrow release condition, a total of $119.4M in cash proceeds will be automatically released by TSX Trust Company, as subscription receipt agent, to the Corporation, and the Subscription Receipts will convert, without any action on the part of the holders thereof, into the underlying securities. RNGTF Osisko Development $3.26 / + (+0.00%) ODV Osisko Development / +

2022-05-23 07:35:20

RNGTF

Osisko Development

$3.26 / + (+0.00%)

, ODV

Osisko Development

/ +

07:35

05/23/22

05/23

07:35

05/23/22

07:35

Osisko Development to commence trading on New York Stock Exchange

Osisko Development is pleased to announce that it has been approved to list its common shares on the New York Stock Exchange. The Common Shares are expected to commence trading on the NYSE on May 27, 2022 under the trading ticker symbol "ODV". Osisko Development will retain its listing on the TSX Venture Exchange under the symbol "ODV". Upon the Common Shares commencing trading on the NYSE, the escrow release condition relating to the subscription receipts of the Corporation issued on March 4, 2022, March 29, 2022 and April 21, 2022 will be satisfied. Upon the satisfaction of such escrow release condition, a total of $119.4M in cash proceeds will be automatically released by TSX Trust Company, as subscription receipt agent, to the Corporation, and the Subscription Receipts will convert, without any action on the part of the holders thereof, into the underlying securities.

RNGTF

Osisko Development

$3.26 / + (+0.00%)

ODV

Osisko Development

/ +

OTHER BREAKING NEWS FROM THE FLY

Downgrade	Aegon downgraded to Underperform from Neutral at Exane BNP Paribas » 05:22 07/05/22 07/05 05:22 07/05/22 05:22 AEG Aegon $4.50 / +0.115 (+2.63%) Exane BNP Paribas analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly AEG Aegon $4.50 / +0.115 (+2.63%) 05/23/22 Aegon sells 50% stake in Spanish joint venture with Liberbank to Unicaja 03/23/22 Aegon announces intention to return cash to shareholders via EUR 300M buyback 02/02/22 Aegon to appoint Deborah Waters as Chief Technology Officer AEG Aegon $4.50 / +0.115 (+2.63%) 06/07/22 Barclays Aegon price target raised to EUR 5.30 from EUR 5 at Barclays 05/23/22 Credit Suisse Aegon price target raised to EUR 5.80 from EUR 5.60 at Credit Suisse 04/05/22 Morgan Stanley Aegon price target raised to EUR 5.40 from EUR 5.30 at Morgan Stanley 04/01/22 Credit Suisse Aegon price target raised to EUR 5.60 from EUR 5.30 at Credit Suisse AEG Aegon $4.50 / +0.115 (+2.63%) 03/23/22 What You Missed On Wall Street On Wednesday 03/23/22 What You Missed On Wall Street This Morning
Downgrade	Fielmann downgraded to Hold from Buy at Kepler Cheuvreux » 05:22 07/05/22 07/05 05:22 07/05/22 05:22 FLMNF Fielmann $54.04 / + (+0.00%) Kepler Cheuvreux analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Upgrade	Antero Resources upgraded to Buy from Hold at Truist » 05:21 07/05/22 07/05 05:21 07/05/22 05:21 AR Antero Resources $30.76 / +0.14 (+0.46%) Truist analyst Neal… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Options AR Antero Resources $30.76 / +0.14 (+0.46%) 06/14/22 Antero Resources falls -9.5% 06/14/22 Antero Resources falls -9.7% 05/19/22 Antero Resources director sells $34.8M in common stock 03/06/22 Fly Intel: Top five weekend stock stories AR Antero Resources $30.76 / +0.14 (+0.46%) 06/22/22 Raymond James Antero Resources added to Analyst Current Favorites list at Raymond James 06/16/22 Raymond James Antero Resources price target raised to $60 from $52 at Raymond James 05/31/22 Mizuho Antero Resources price target raised to $59 from $56 at Mizuho 04/25/22 Raymond James Antero Resources price target raised to $52 from $38 at Raymond James AR Antero Resources $30.76 / +0.14 (+0.46%) 04/27/22 Antero Resources reports Q1 adjusted EPS $1.15, consensus $1.10 02/16/22 Antero Resources reports Q4 EPS 46c, consensus 68c AR Antero Resources $30.76 / +0.14 (+0.46%) 03/05/22 EQT, Chesapeake among stocks to play rally in natural gas, Barron's says AR Antero Resources $30.76 / +0.14 (+0.46%) 06/30/22 Unusually active option classes on open June 30th 06/15/22 Unusually active option classes on open June 15th 06/15/22 Antero Resources put buyer realizes 168% same-day gains 06/14/22 Unusually active option classes on open June 14th
Upgrade	Dechra upgraded to Outperform from Sector Perform at RBC Capital » 05:19 07/05/22 07/05 05:19 07/05/22 05:19 DCHPF Dechra Pharmaceuticals $39.00 / + (+0.00%) RBC Capital analyst Zoe… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research DCHPF Dechra Pharmaceuticals $39.00 / + (+0.00%) 02/23/22 Liberum Dechra Pharmaceuticals upgraded to Hold from Sell at Liberum 02/21/22 Panmure Gordon Dechra Pharmaceuticals upgraded to Buy from Hold at Panmure Gordon 01/04/22 JPMorgan Dechra price target raised to 5,700 GBp from 5,400 GBp at JPMorgan 12/03/21 RBC Capital Dechra price target raised to 5,300 GBp from 4,400 GBp at RBC Capital
Hot Stocks	Fluence Energy announces strategic partnership with Rich Electric » 05:18 07/05/22 07/05 05:18 07/05/22 05:18 FLNC Fluence Energy $9.01 / -0.435 (-4.61%) Fluence Energy announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options FLNC Fluence Energy $9.01 / -0.435 (-4.61%) 06/14/22 Fluence Energy announces training platform for energy storage systems 05/12/22 Fluence Energy trading resumes 05/12/22 Fluence Energy trading halted, volatility trading pause 05/05/22 Fluence Energy partners with Amazon.com for cloud computing services FLNC Fluence Energy $9.01 / -0.435 (-4.61%) 05/18/22 RBC Capital Fluence Energy price target lowered to $18 from $28 at RBC Capital 05/16/22 Credit Suisse Fluence Energy price target lowered to $29 from $37 at Credit Suisse 05/13/22 Baird Fluence Energy price target lowered to $15 from $25 at Baird 05/13/22 Goldman Sachs Fluence Energy downgraded to Neutral from Buy at Goldman Sachs FLNC Fluence Energy $9.01 / -0.435 (-4.61%) 05/11/22 Fluence Energy backs FY22 revenue view $1.1B-$1.3B, consensus $1.12B 05/11/22 Fluence Energy reports Q2 EPS (35c), consensus (32c) 02/09/22 Fluence Energy reports Q1 EPS (53c), consensus (30c) 28 Oct FLNC Fluence Energy $9.01 / -0.435 (-4.61%) 05/12/22 What You Missed On Wall Street This Morning FLNC Fluence Energy $9.01 / -0.435 (-4.61%) 01/19/22 Four new option listings and two option delistings on January 19th
Upgrade	PGS ASA upgraded to Buy from Hold at Pareto » 05:16 07/05/22 07/05 05:16 07/05/22 05:16 PGEJF PGS ASA / + Pareto analyst Bard Rosef… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Hot Stocks	Cognizant selected as strategic technology provider by NICL » 05:16 07/05/22 07/05 05:16 07/05/22 05:16 CTSH Cognizant $68.03 / +0.54 (+0.80%) Cognizant announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly CTSH Cognizant $68.03 / +0.54 (+0.80%) 06/28/22 Cognizant terminates Americas leader immediately due to behavior 04/19/22 Unisys appoints Caludius Sokenu as General Counsel and Secretary 02/09/22 Cognizant renews contract with Volvo Cars for three years 02/02/22 Cognizant raises quarterly dividend 12% to 27c per share CTSH Cognizant $68.03 / +0.54 (+0.80%) 05/09/22 Cowen Cognizant price target lowered to $95 from $98 at Cowen 05/05/22 Citi Cognizant price target lowered to $88 from $95 at Citi 02/07/22 Barclays Cognizant price target raised to $85 from $78 at Barclays 02/03/22 BMO Capital Cognizant price target raised to $100 from $92 at BMO Capital CTSH Cognizant $68.03 / +0.54 (+0.80%) 05/04/22 Cognizant sees Q2 revenue $4.9B-$4.94B, consensus $5.01B 05/04/22 Cognizant cuts FY22 adjusted EPS view to $4.45-$4.55 from $4.46-$4.60 05/04/22 Cognizant reports Q1 adjusted EPS $1.08, consensus $1.04 05/04/22 Notable companies reporting after market close CTSH Cognizant $68.03 / +0.54 (+0.80%) 05/04/22 Fly Intel: After-Hours Movers 02/02/22 Fly Intel: After-Hours Movers
Recommendations	Bottom in med tech shares is 'getting close,' says Piper Sandler » 05:14 07/05/22 07/05 05:14 07/05/22 05:14 BSX Boston Scientific $37.99 / +0.73 (+1.96%) , HSIC Henry Schein $77.08 / +0.35 (+0.46%) , ATRC AtriCure $41.03 / +0.22 (+0.54%) , AXNX Axonics $57.99 / +1.44 (+2.55%) , LIVN LivaNova $63.33 / +1.03 (+1.65%) , PDCO Patterson Companies $30.60 / +0.39 (+1.29%) , TNDM TNDM / + Piper Sandler analysts… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options BSX HSIC ATRC AXNX LIVN PDCO TNDM BSX Boston Scientific $37.99 / +0.73 (+1.96%) 06/15/22 Boston Scientific to buy majority stake in M.I.Tech Co. for $230M 03/16/22 Sight Sciences appoints Brenda Becker to board of directors 02/18/22 FTC approves changes to Boston Scientific divestiture agreement HSIC Henry Schein $77.08 / +0.35 (+0.46%) 06/07/22 Henry Schein to acquire Condor Dental, terms not disclosed 04/04/22 Henry Schein says CAO Gerald Benjamin to retire, Michael Ettinger named COO 01/05/22 Henry Schein CFO Steven Paladino to retire, Ronald South to succeed ATRC AtriCure $41.03 / +0.22 (+0.54%) 06/07/22 AtriCure announces first patient treated in HEAL-IST clinical trial 06/01/22 AtriCure appoints Deborah Yount Chief Human Resources Officer AXNX Axonics $57.99 / +1.44 (+2.55%) 05/31/22 Axonics files premarket approval supplement with FDA for its sacral INS 03/07/22 Axonics receives FDA approval for recharge-free sacral neuromodulation system LIVN LivaNova $63.33 / +1.03 (+1.65%) 05/16/22 David Einhorn's Greenlight adds Southwestern, exits Sonos in Q1 04/08/22 LivaNova announces receipt of regulatory approvals for, launch of Essenz 03/14/22 LivaNova says 250th unipolar depression patient implanted in study 02/24/22 LivaNova says first patient implanted in OSPREY study of aura6000 PDCO Patterson Companies $30.60 / +0.39 (+1.29%) 06/01/22 Duke Realty names Scott Anderson to board of directors TNDM TNDM / + 02/16/22 Tandem Diabetes announces FDA clearance for t:slim X2 insulin pump BSX HSIC ATRC AXNX LIVN PDCO TNDM BSX Boston Scientific $37.99 / +0.73 (+1.96%) 06/29/22 Canaccord Boston Scientific price target lowered to $43 from $51 at Canaccord 06/24/22 BTIG Boston Scientific price target lowered to $45 from $52 at BTIG 06/15/22 Piper Sandler Piper Sandler overall constructive on Boston Scientific's MedSurg business deal 05/27/22 Needham Needham upgrades Boston Scientific to Buy, sees stock as potential M&A target HSIC Henry Schein $77.08 / +0.35 (+0.46%) 06/17/22 Stifel Henry Schein price target lowered to $80 from $90 at Stifel 06/14/22 Baird Baird downgrades Henry Schein to Neutral after dental survey points to slowing 06/14/22 Baird Henry Schein downgraded to Neutral from Outperform at Baird 05/12/22 Credit Suisse Henry Schein assumed with an Outperform at Credit Suisse ATRC AtriCure $41.03 / +0.22 (+0.54%) 06/28/22 Needham AtriCure price target lowered to $55 from $67 at Needham 06/24/22 BTIG AtriCure price target lowered to $75 from $94 at BTIG 05/04/22 Needham AtriCure price target lowered to $67 from $79 at Needham 04/19/22 Piper Sandler Piper Sandler continues to recommend exposure to medtech space after J&J results AXNX Axonics $57.99 / +1.44 (+2.55%) 05/06/22 Piper Sandler Axonics price target raised to $77 from $75 at Piper Sandler 04/05/22 Wolfe Research Axonics initiated with an Outperform at Wolfe Research 03/14/22 Piper Sandler Axonics remains 'high-conviction idea' at Piper Sandler 03/07/22 Piper Sandler Timing of Axonics' SNM solutions approval in line with expectations, says Piper LIVN LivaNova $63.33 / +1.03 (+1.65%) 05/05/22 Piper Sandler LivaNova price target lowered to $99 from $104 at Piper Sandler 04/05/22 Wolfe Research LivaNova initiated with an Outperform at Wolfe Research 03/14/22 Piper Sandler LivaNova study milestone should be well received, says Piper Sandler 02/24/22 UBS LivaNova upgraded to Buy from Neutral at UBS PDCO Patterson Companies $30.60 / +0.39 (+1.29%) 06/29/22 Piper Sandler Patterson Companies price target raised to $42 from $41 at Piper Sandler 05/12/22 Credit Suisse Patterson Companies assumed with an Outperform at Credit Suisse 03/02/22 Piper Sandler Piper says Patterson results should be 'more than enough' to support move higher 02/01/22 Baird Dental survey results for January 'aren't pretty,' says Baird TNDM TNDM / + 06/01/22 Lake Street Abbott approval for Libre 3 'a huge positive' for Tandem, says Lake Street 05/31/22 Piper Sandler Abbott approval bodes well for DexCom, Tandem, says Piper Sandler 05/31/22 Wells Fargo Wells Fargo glad DexCom, Insulet merger is not happening 05/25/22 Lake Street Lake Street says diabetes industry consolidation unlikely to hurt Tandem BSX HSIC ATRC AXNX LIVN PDCO TNDM BSX Boston Scientific $37.99 / +0.73 (+1.96%) 04/27/22 Boston Scientific sees FY22 adjusted EPS $1.74-$1.79, consensus $1.77 04/27/22 Boston Scientific sees Q2 adjusted EPS 41c-43c consensus 44c 04/27/22 Boston Scientific reports Q1 adjusted EPS 39c, consensus 39c 04/26/22 Notable companies reporting before tomorrow's open HSIC Henry Schein $77.08 / +0.35 (+0.46%) 05/03/22 Henry Schein reaffirms FY22 GAAP EPS $4.75-$4.91, consensus $4.86 05/03/22 Henry Schein reports Q1 non-GAAP EPS $1.24, consensus $1.19 02/15/22 Henry Schein sees FY22 GAAP EPS $4.75-$4.91, consensus $4.63 02/15/22 Henry Schein reports Q4 adjusted EPS $1.07, consensus 91c ATRC AtriCure $41.03 / +0.22 (+0.54%) 05/03/22 AtriCure backs FY22 EPS view of ($1.12) to ($1.07), consensus ($1.05) 05/03/22 AtriCure reports Q1 EPS (33c), consensus (32c) 02/15/22 AtriCure sees FY22 adjusted EPS ($1.12)-($1.07), consensus (94c) 02/15/22 AtriCure reports Q4 adjusted EPS (30c), consensus (29c) AXNX Axonics $57.99 / +1.44 (+2.55%) 05/05/22 Axonics raises FY22 revenue view to $238M from $234M, consensus $234.1M 05/05/22 Axonics reports Q1 EPS (50c), consensus (63c) 02/24/22 Axonics sees FY22 revenue $234M, consensus $231.2M 02/24/22 Axonics reports Q4 EPS (34c), consensus (37c) LIVN LivaNova $63.33 / +1.03 (+1.65%) 05/04/22 LivaNova still sees 2022 adjusted EPS $2.50-$2.80,consensus $2.59 05/04/22 LivaNova reports Q1 adjusted EPS 48c, consensus 48c 02/23/22 LivaNova sees 2022 adjusted EPS $2.50-$2.80, consensus $2.56 02/23/22 LivaNova reports Q4 adjusted EPS 57c, consensus 52c PDCO Patterson Companies $30.60 / +0.39 (+1.29%) 06/29/22 Patterson Companies sees FY23 EPS $2.25 to $2.35, consensus $2.24 06/29/22 Patterson Companies reports Q4 EPS71c, consensus 55c 03/02/22 Patterson Companies raises FY22 EPS view to $2.08 -$2.13 , consensus $2.07 03/02/22 Patterson Companies reports Q3 EPS 55c, consensus 47c TNDM TNDM / + 05/04/22 Tandem Diabetes raises FY22 revenue view to $850M-$865M, consensus $846.54M 05/04/22 Tandem Diabetes reports Q1 EPS (23c), consensus (7c) 02/22/22 Tandem Diabetes sees FY22 revenue $845M-$860M, consensus $827.2M 02/22/22 Tandem Diabetes reports Q4 EPS 16c, consensus 21c 04 Aug BSX HSIC PDCO BSX Boston Scientific $37.99 / +0.73 (+1.96%) 04/27/22 Fly Intel: Pre-market Movers 02/02/22 Fly Intel: Pre-market Movers HSIC Henry Schein $77.08 / +0.35 (+0.46%) 06/14/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/31/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations PDCO Patterson Companies $30.60 / +0.39 (+1.29%) 06/29/22 What You Missed On Wall Street On Wednesday 06/29/22 What You Missed On Wall Street This Morning 06/29/22 Fly Intel: Pre-market Movers 03/02/22 What You Missed On Wall Street On Wednesday 09/07/22 2022 Wells Fargo Healthcare Conference 07/27/22 Boston Scientific - BSX 08/03/22 LivaNova - LIVN BSX HSIC BSX Boston Scientific $37.99 / +0.73 (+1.96%) 06/24/22 Boston Scientific call volume above normal and directionally bullish 06/17/22 Boston Scientific call volume above normal and directionally bullish 06/13/22 Boston Scientific call volume above normal and directionally bullish 06/10/22 Boston Scientific call volume above normal and directionally bullish HSIC Henry Schein $77.08 / +0.35 (+0.46%) 06/29/22 Early notable gainers among liquid option names on June 29th
Hot Stocks	AST SpaceMobile to sell majority ownership stake in NanoAvionics for $68M » 05:13 07/05/22 07/05 05:13 07/05/22 05:13 ASTS AST SpaceMobile $6.33 / +0.065 (+1.04%) AST SpaceMobile announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Options ASTS AST SpaceMobile $6.33 / +0.065 (+1.04%) 06/29/22 AST SpaceMobile updates BlueWalker 3 launch timing for early to mid-September 05/02/22 AST receives experimental license from FCC for BlueWalker 3 satellite 04/29/22 AST SpaceMobile announces Sean Wallace as CFO 04/28/22 AST SpaceMobile enters collaboration with Globe Telecom ASTS AST SpaceMobile $6.33 / +0.065 (+1.04%) 05/24/22 Deutsche Bank AST SpaceMobile price target lowered to $31 from $32 at Deutsche Bank 04/01/22 Deutsche Bank AST SpaceMobile price target lowered to $32 from $35 at Deutsche Bank 07/12/21 Barclays AST SpaceMobile initiated with an Overweight at Barclays ASTS AST SpaceMobile $6.33 / +0.065 (+1.04%) 05/20/22 Proven algorithm says sell these stocks now 04/29/22 Proven algorithm says sell these stocks now 03/09/22 What You Missed On Wall Street On Wednesday 03/09/22 What You Missed On Wall Street This Morning ASTS AST SpaceMobile $6.33 / +0.065 (+1.04%) 05/16/22 AST SpaceMobile options imply 12.8% move in share price post-earnings 03/31/22 AST SpaceMobile options imply 10.0% move in share price post-earnings 03/09/22 Unusually active option classes on open March 9th 03/03/22 Largest borrow rate increases among liquid names
Hot Stocks	Elbit Systems awarded $80M contract to supply DIRCM, EW systems » 05:12 07/05/22 07/05 05:12 07/05/22 05:12 ESLT Elbit Systems $227.66 / -3.21 (-1.39%) Elbit Systems announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings On The Fly ESLT Elbit Systems $227.66 / -3.21 (-1.39%) 06/30/22 Elbit Systems awarded $548M contract to supply networked warfare capabilities 06/29/22 Elbit Systems awarded roughly $220M airborne precision munition contract 06/27/22 Elbit Systems awarded $70M contract to provide EW solution to customer 05/16/22 Elbit Systems subsidiary awarded $49M delivery order ESLT Elbit Systems $227.66 / -3.21 (-1.39%) 03/29/22 Elbit Systems reports Q4 EPS $2.14 vs. $2.38 last year ESLT Elbit Systems $227.66 / -3.21 (-1.39%) 03/29/22 Fly Intel: Pre-market Movers

Hot Stocks	InterDigital signs multi-year royalty bearing license with Zebra Technologies » 05:09 07/05/22 07/05 05:09 07/05/22 05:09 IDCC InterDigital $60.60 / -0.82 (-1.34%) , ZBRA Zebra Technologies $299.20 / +6.75 (+2.31%) InterDigital (IDCC)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options IDCC ZBRA IDCC InterDigital $60.60 / -0.82 (-1.34%) 06/23/22 InterDigital appoints Rajesh Pankaj as CTO 02/28/22 InterDigital, Zip Code Wilmington expand partnership 01/10/22 InterDigital, Sony Corporation of America extend pact and renew patent license ZBRA Zebra Technologies $299.20 / +6.75 (+2.31%) 06/30/22 Zebra Technologies to pay $360M in patent-related settlement with Honeywell 05/17/22 Zebra Technologies announces additional $1B share repurchase program 03/15/22 Zebra to acquire machine vision company Matrox Imaging for $875M IDCC ZBRA IDCC InterDigital $60.60 / -0.82 (-1.34%) 08/03/21 Roth Capital Court ruling sets tone for unlicensed Chinese OEMs in Europe, says Roth Capital ZBRA Zebra Technologies $299.20 / +6.75 (+2.31%) 05/23/22 Morgan Stanley Zebra Technologies assumed at Equal Weight from Underweight at Morgan Stanley 05/04/22 Needham Zebra Technologies price target lowered to $500 from $535 at Needham 05/04/22 Baird Zebra Technologies price target lowered to $440 from $550 at Baird 04/12/22 Morgan Stanley Morgan Stanley cuts Telecom & Networking Equipment industry view to Cautious IDCC ZBRA IDCC InterDigital $60.60 / -0.82 (-1.34%) 06/28/22 InterDigital raises Q2 revenue view to $120M-$124M from $114M-$120M 05/05/22 InterDigital sees Q2 revenue $114M-$120M, two est. $100M 05/05/22 InterDigital reports Q1 EPS 58c vs. 18c last year 02/17/22 InterDigital sees Q1 revenue $95M-$100M, two est. $99.79M ZBRA Zebra Technologies $299.20 / +6.75 (+2.31%) 05/03/22 Zebra Technologies sees FY22 revenue growth of 3%-7%, consensus $5.95B 05/03/22 Zebra Technologies sees Q2 adjusted EPS $4.05 -$4.35, consensus $4.52 05/03/22 Zebra Technologies reports Q1 adjusted EPS $4.01, consensus $3.87 02/10/22 Zebra Technologies sees FY22 revenue growth of 3%-7%, consensus $5.92B IDCC ZBRA IDCC InterDigital $60.60 / -0.82 (-1.34%) 06/28/22 What You Missed On Wall Street On Tuesday 06/28/22 What You Missed On Wall Street This Morning 05/25/22 What You Missed On Wall Street On Wednesday 05/25/22 What You Missed On Wall Street This Morning ZBRA Zebra Technologies $299.20 / +6.75 (+2.31%) 05/23/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/04/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 09/12/22 Zebra Technologies - ZBRA ZBRA ZBRA Zebra Technologies $299.20 / +6.75 (+2.31%) 04/04/22 Early notable gainers among liquid option names on April 4th
Hot Stocks	Nokia wins five-year 5G deal with Ice » 05:07 07/05/22 07/05 05:07 07/05/22 05:07 NOK Nokia $4.66 / +0.04 (+0.87%) Nokia announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NOK Nokia $4.66 / +0.04 (+0.87%) 06/14/22 Nokia to help Wire 3 accelerate 10G broadband network build in Florida 06/13/22 Nokia announces Metronet deployment of PON technology 06/13/22 Nokia, Innventure announce plans to commercialize cooling technology 05/26/22 Nokia, TWM announce 5G coverage expansion deal NOK Nokia $4.66 / +0.04 (+0.87%) 06/14/22 Citi Nokia upgraded to Buy from Neutral at Citi 05/18/22 Deutsche Bank Nokia price target lowered to EUR 6 from EUR 6.50 at Deutsche Bank 05/13/22 AlphaValue/Baader Nokia upgraded to Buy from Add at AlphaValue/Baader 04/29/22 UBS Nokia price target lowered to EUR 5.80 from EUR 6.20 at UBS NOK Nokia $4.66 / +0.04 (+0.87%) 04/28/22 Nokia raises FY22 revenue view to EUR 22.9B-EUR 24.1B from EUR 22.6B-EUR 23.8B 04/28/22 Nokia reports Q1 comparable EPS EUR 0.07 vs EUR 0.07 last year 02/03/22 Nokia sees FY22 revenue EUR 22.6B-EUR 23.8B 02/03/22 Nokia reports Q4 comparable EPS EUR0.13 vs. EUR 0.14 last year NOK Nokia $4.66 / +0.04 (+0.87%) 02/19/22 Might be the time to plug into Nokia's stock, Barron's says NOK Nokia $4.66 / +0.04 (+0.87%) 04/12/22 What You Missed On Wall Street On Tuesday 04/12/22 What You Missed On Wall Street This Morning 03/14/22 What You Missed On Wall Street On Monday 03/14/22 What You Missed On Wall Street This Morning NOK Nokia $4.66 / +0.04 (+0.87%) 05/12/22 Unusually active option classes on open May 12th 05/10/22 Unusually active option classes on open May 10th 04/28/22 Unusually active option classes on open April 28th 04/27/22 Nokia call volume above normal and directionally bullish
Recommendations	Wynn Resorts price target lowered to $87.50 from $92 at Citi » 05:06 07/05/22 07/05 05:06 07/05/22 05:06 WYNN Wynn Resorts $58.15 / +1.205 (+2.12%) Citi analyst George Choi… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options WYNN Wynn Resorts $58.15 / +1.205 (+2.12%) 07/01/22 Macau reports June casino revenue down 62.1% to 2.48B patacas 06/30/22 Nevada reports May statewide gaming win up 5.71% to $1.3B 06/23/22 Wynn Resorts Macau announces concession extension agreement 06/16/22 New Jersey reports May gaming revenue up 15.1% to $430.6M WYNN Wynn Resorts $58.15 / +1.205 (+2.12%) 06/29/22 Barclays Barclays initiates gaming sector, says Caesars best positioned 06/28/22 Barclays Wynn Resorts initiated with an Equal Weight at Barclays 05/11/22 Deutsche Bank Wynn Resorts price target lowered to $92 from $123 at Deutsche Bank 05/11/22 Wells Fargo Wynn Resorts price target lowered to $79 from $97 at Wells Fargo WYNN Wynn Resorts $58.15 / +1.205 (+2.12%) 05/10/22 Wynn Resorts reports Q1 adjusted EPS ($1.21), consensus ($1.15) 05/10/22 Notable companies reporting after market close 02/15/22 Wynn Resorts reports Q4 EPS ($1.54), consensus ($1.25) 02/15/22 Notable companies reporting after market close WYNN Wynn Resorts $58.15 / +1.205 (+2.12%) 06/23/22 Fanatics in discussions to enter sports betting business, CNBC reports 06/20/22 China-listed Macau stocks slide after outbreak in region, Bloomberg reports 06/17/22 Casino stocks plummeting amid inflation, recession fears, CNBC says 03/14/22 Macau imposes more quarantine rules, GGR Asia reports WYNN Wynn Resorts $58.15 / +1.205 (+2.12%) 07/01/22 Bet On It: Bally's enters sale-leaseback for Rhode Island casinos 06/29/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/24/22 Bet On It: Fanatics looks to enter sports betting space 06/17/22 Bet On It: Maryland governor calls for online sports betting timeline WYNN Wynn Resorts $58.15 / +1.205 (+2.12%) 06/28/22 Early notable gainers among liquid option names on June 28th 06/24/22 Early notable gainers among liquid option names on June 24th 06/15/22 Unusually active option classes on open June 15th 06/08/22 Early notable gainers among liquid option names on June 8th
Recommendations	MGM Resorts price target lowered to $56 from $59 at Citi » 05:06 07/05/22 07/05 05:06 07/05/22 05:06 MGM MGM Resorts $30.00 / +1.05 (+3.63%) Citi analyst George Choi… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options MGM MGM Resorts $30.00 / +1.05 (+3.63%) 07/01/22 Macau reports June casino revenue down 62.1% to 2.48B patacas 06/30/22 Nevada reports May statewide gaming win up 5.71% to $1.3B 06/27/22 BetMGM to become exclusive sportsbook of Audacy's BetQL Network 06/21/22 BetMGM, Sony Pictures Television, IGT to launch online Wheel of Fortune casino MGM MGM Resorts $30.00 / +1.05 (+3.63%) 06/28/22 JMP Securities MGM Resorts initiated with an Outperform at JMP Securities 05/20/22 Deutsche Bank MGM Resorts price target lowered to $48 from $52 at Deutsche Bank 05/11/22 Oppenheimer IAC price target lowered to $135 from $155 at Oppenheimer 05/03/22 CBRE MGM Resorts 'primed for firing on all cylinders,' says CBRE MGM MGM Resorts $30.00 / +1.05 (+3.63%) 05/09/22 IAC reports Q1 EPS ($2.72), consensus (75c) 05/02/22 MGM Resorts reports Q1 adjusted EPS 1c, consensus (7c) 05/02/22 Notable companies reporting after market close 02/09/22 MGM Resorts reports Q4 adjusted EPS 12c, consensus 2c MGM MGM Resorts $30.00 / +1.05 (+3.63%) 07/01/22 MGM, Caesars reach tenative deals with Atlantic City workers, WSJ says 06/23/22 Fanatics in discussions to enter sports betting business, CNBC reports 06/20/22 China-listed Macau stocks slide after outbreak in region, Bloomberg reports 06/17/22 Casino stocks plummeting amid inflation, recession fears, CNBC says MGM MGM Resorts $30.00 / +1.05 (+3.63%) 07/01/22 Bet On It: Bally's enters sale-leaseback for Rhode Island casinos 06/28/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/24/22 Bet On It: Fanatics looks to enter sports betting space 06/17/22 Bet On It: Maryland governor calls for online sports betting timeline MGM MGM Resorts $30.00 / +1.05 (+3.63%) 06/16/22 MGM Resorts put volume heavy and directionally bearish 06/10/22 MGM Resorts put volume heavy and directionally bearish 05/02/22 MGM Resorts options imply 5.5% move in share price post-earnings 04/06/22 MGM Resorts put volume heavy and directionally bearish
Recommendations	Melco Resorts price target lowered to $11 from $12.50 at Citi » 05:06 07/05/22 07/05 05:06 07/05/22 05:06 MLCO Melco Resorts & Entertainment $6.01 / +0.255 (+4.43%) Citi analyst George Choi… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options MLCO Melco Resorts & Entertainment $6.01 / +0.255 (+4.43%) 07/01/22 Macau reports June casino revenue down 62.1% to 2.48B patacas 06/23/22 Studio City's gaming concessions in Macau extended to December 31 06/23/22 Melco Resorts & Entertainment's gaming subconcession in Macau extended 06/01/22 Macau reports May casino revenue down 68.0% to 3.34B patacas MLCO Melco Resorts & Entertainment $6.01 / +0.255 (+4.43%) 05/09/22 CICC Melco Resorts downgraded to Market Perform from Outperform at CICC 05/06/22 CLSA Melco Resorts & Entertainment upgraded to Buy from Outperform at CLSA 04/12/22 Citi Citi opens '30-day positive Catalyst Watches' on Melco, Galaxy 01/18/22 Citi Melco Resorts & Entertainment price target raised to $15 from $13.50 at Citi MLCO Melco Resorts & Entertainment $6.01 / +0.255 (+4.43%) 05/05/22 Melco Resorts & Entertainment reports Q1 EPS 38.8c vs 48.8c last year 03/01/22 Melco Resorts & Entertainment reports Q4 EPS (11.2c) vs. (14c) last year MLCO Melco Resorts & Entertainment $6.01 / +0.255 (+4.43%) 06/20/22 China-listed Macau stocks slide after outbreak in region, Bloomberg reports 03/14/22 Macau imposes more quarantine rules, GGR Asia reports 01/14/22 Macau to award maximum of six casino licenses, Bloomberg reports MLCO Melco Resorts & Entertainment $6.01 / +0.255 (+4.43%) 07/01/22 Bet On It: Bally's enters sale-leaseback for Rhode Island casinos 06/24/22 Bet On It: Fanatics looks to enter sports betting space 06/03/22 Bet On It: Government wins as sportsbooks lose in New York sports betting market 05/06/22 What You Missed On Wall Street On Friday MLCO Melco Resorts & Entertainment $6.01 / +0.255 (+4.43%) 06/08/22 Unusually active option classes on open June 8th 05/23/22 Unusually active option classes on open May 23rd 03/11/22 Melco Resorts put volume heavy and directionally bearish 02/14/22 Melco Resorts call volume above normal and directionally bullish
Recommendations	Las Vegas Sands price target lowered to $56 from $57 at Citi » 05:05 07/05/22 07/05 05:05 07/05/22 05:05 LVS Las Vegas Sands $35.28 / +1.67 (+4.97%) Citi analyst George Choi… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options LVS Las Vegas Sands $35.28 / +1.67 (+4.97%) 07/04/22 Fly Intel: Top five weekend stock stories 07/01/22 Macau reports June casino revenue down 62.1% to 2.48B patacas 06/30/22 Nevada reports May statewide gaming win up 5.71% to $1.3B 06/28/22 Las Vegas Sands rises 9.0% LVS Las Vegas Sands $35.28 / +1.67 (+4.97%) 06/29/22 Barclays Barclays initiates gaming sector, says Caesars best positioned 06/28/22 Barclays Barclays says shift in preferences to cushion Gaming, Cruises, Timeshare names 06/28/22 Barclays Las Vegas Sands initiated with an Overweight at Barclays 04/28/22 Stifel Las Vegas Sands price target lowered to $46 from $56 at Stifel LVS Las Vegas Sands $35.28 / +1.67 (+4.97%) 04/27/22 Las Vegas Sands reports Q1 consolidated adjusted property EBITDA $110M 04/27/22 Las Vegas Sands reports Q1 adjusted EPS (40c), consensus (24c) 04/27/22 Notable companies reporting after market close 01/26/22 Las Vegas Sands reports Q4 adjusted EPS (22c), consensus (25c) LVS Las Vegas Sands $35.28 / +1.67 (+4.97%) 07/02/22 Las Vegas Sands could win big as China eases COVID rules, Barron's says 06/23/22 Fanatics in discussions to enter sports betting business, CNBC reports 06/20/22 China-listed Macau stocks slide after outbreak in region, Bloomberg reports 06/17/22 Casino stocks plummeting amid inflation, recession fears, CNBC says LVS Las Vegas Sands $35.28 / +1.67 (+4.97%) 07/01/22 Bet On It: Bally's enters sale-leaseback for Rhode Island casinos 06/29/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/24/22 Bet On It: Fanatics looks to enter sports betting space 06/17/22 Bet On It: Maryland governor calls for online sports betting timeline LVS Las Vegas Sands $35.28 / +1.67 (+4.97%) 06/28/22 Early notable gainers among liquid option names on June 28th 06/06/22 Early notable gainers among liquid option names on June 6th 05/16/22 Las Vegas Sands call buyer realizes 33% same-day gains 05/13/22 Early notable gainers among liquid option names on May 13th
Hot Stocks	Natuzzi shareholders approve new stock option plan » 05:05 07/05/22 07/05 05:05 07/05/22 05:05 NTZ Natuzzi $7.92 / +0.4 (+5.32%) Natuzzi announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News On The Fly NTZ Natuzzi $7.92 / +0.4 (+5.32%) 05/19/22 Natuzzi board approves proposal to approve new stock option plan 05/11/22 Natuzzi signs partnership agreement with Truong Thanh Furniture 01/31/22 Natuzzi falls -7.0% 01/28/22 Natuzzi falls -11.7% NTZ Natuzzi $7.92 / +0.4 (+5.32%) 01/13/22 Fly Intel: After-Hours Movers
Recommendations	Citi opens '90-day positive Catalyst Watch' on MakeMyTrip » 05:01 07/05/22 07/05 05:01 07/05/22 05:01 MMYT MakeMyTrip $25.90 / +0.2 (+0.78%) Citi analyst Vijit Jain… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly MMYT MakeMyTrip $25.90 / +0.2 (+0.78%) 04/05/22 MakeMyTrip's fintech arm buys majority stake in India's BookMyForex MMYT MakeMyTrip $25.90 / +0.2 (+0.78%) 06/13/22 UBS MakeMyTrip upgraded to Buy from Sell at UBS (earlier) 05/26/22 Citi MakeMyTrip price target raised to $43 from $42 at Citi 02/24/22 Morgan Stanley MakeMyTrip initiated with an Equal Weight at Morgan Stanley 10/27/21 Citi MakeMyTrip price target raised to $42 from $38 at Citi MMYT MakeMyTrip $25.90 / +0.2 (+0.78%) 05/25/22 MakeMyTrip reports Q4 adjusted EPS 8c vs. 11c last year 01/25/22 MakeMyTrip reports Q3 adjusted EPS 12c, two est. (1c) MMYT MakeMyTrip $25.90 / +0.2 (+0.78%) 02/24/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Initiation	Greentown Management initiated with a Buy at Citi » 04:58 07/05/22 07/05 04:58 07/05/22 04:58 GRMHF Greentown Management / + Citi analyst Cindy Li… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Hot Stocks	Enhabit to replace Loyalty Ventures in S&P 600 at open on 7/5 » 04:55 07/05/22 07/05 04:55 07/05/22 04:55 EHAB Enhabit $22.50 / -0.5 (-2.17%) , LYLT Loyalty Ventures $3.53 / -0.075 (-2.08%) , EHC Encompass Health $46.53 / -9.485 (-16.93%) Encompass Health (EHC) is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options EHAB LYLT EHC EHAB Enhabit $22.50 / -0.5 (-2.17%) 04:55 Today Enhabit to replace Loyalty Ventures in S&P 600 at open on 7/5 07/01/22 Encompass Health completes spin off of Enhabit 06/28/22 Enhabit to replace Loyalty Ventures in S&P 600 at open on 7/5 LYLT Loyalty Ventures $3.53 / -0.075 (-2.08%) 04:55 Today Enhabit to replace Loyalty Ventures in S&P 600 at open on 7/5 06/28/22 Enhabit to replace Loyalty Ventures in S&P 600 at open on 7/5 06/09/22 Loyalty Ventures trading resumes 06/09/22 Loyalty Ventures trading halted, volatility trading pause EHC Encompass Health $46.53 / -9.485 (-16.93%) 04:55 Today Enhabit to replace Loyalty Ventures in S&P 600 at open on 7/5 07/01/22 Encompass Health falls -17.7% 07/01/22 Encompass Health falls -20.5% 07/01/22 Encompass Health falls -20.4% EHAB LYLT EHC EHAB Enhabit $22.50 / -0.5 (-2.17%) LYLT Loyalty Ventures $3.53 / -0.075 (-2.08%) 06/08/22 Needham Loyalty Ventures' Sobeys new 'hurts,' but pullback looks overdone, says Needham 06/03/22 Needham Needham starts Loyalty Ventures at Buy on 'attractive' loyalty tech, valuation 06/03/22 Needham Loyalty Ventures initiated with a Buy at Needham 02/25/22 Morgan Stanley Loyalty Ventures initiated with an Equal Weight at Morgan Stanley EHC Encompass Health $46.53 / -9.485 (-16.93%) 06/21/22 Truist Encompass Health price target lowered to $75 from $85 at Truist 06/21/22 Stephens Encompass Health price target lowered to $74 from $78 at Stephens 06/17/22 Raymond James Encompass Health price target lowered to $70 from $85 at Raymond James 06/08/22 RBC Capital Encompass Health price target lowered to $82 from $85 at RBC Capital EHC EHC Encompass Health $46.53 / -9.485 (-16.93%) 06/07/22 Encompass Health provides FY22 guidance for Enhabit spin off 06/07/22 Encompass Health cuts FY22 adjusted EPS view to $3.76-$4.05 from $3.83-$4.19 04/27/22 Encompass Health backs FY22 adjusted EPS view $3.83-$4.19, consensus $4.10 04/27/22 Encompass Health reports Q1 adjusted EPS 97c, consensus 92c EHC EHC Encompass Health $46.53 / -9.485 (-16.93%) 06/24/22 April Anthony tried to buy back Encompass Health for $3.6B, DMN reports 03/07/22 Encompass' home health unit attracts acquisition interest, Reuters reports EHAB EHC EHAB Enhabit $22.50 / -0.5 (-2.17%) 07/01/22 What You Missed On Wall Street On Friday 07/01/22 What You Missed On Wall Street This Morning EHC Encompass Health $46.53 / -9.485 (-16.93%) 07/01/22 What You Missed On Wall Street On Friday 07/01/22 What You Missed On Wall Street This Morning 03/07/22 What You Missed On Wall Street On Monday 08/02/22 Encompass Health - EHC 08/11/22 Encompass Health LYLT EHC LYLT Loyalty Ventures $3.53 / -0.075 (-2.08%) 03/25/22 Three new option listings on March 25th EHC Encompass Health $46.53 / -9.485 (-16.93%) 07/01/22 One new option listing and one option delisting on July 1st 02/01/22 Encompass Health options imply 5.1% move in share price post-earnings

Hot Stocks	Sun Country Airlines to replace Neenah in S&P 600 at open on 7/5 » 04:55 07/05/22 07/05 04:55 07/05/22 04:55 SNCY Sun Country Airlines $18.38 / +0.085 (+0.46%) , NP Neenah $33.77 / -0.37 (-1.08%) , SWM Schweitzer-Mauduit / + SchweitzerMauduit… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly SNCY NP SWM SNCY Sun Country Airlines $18.38 / +0.085 (+0.46%) 04:55 Today Sun Country Airlines to replace Neenah in S&P 600 at open on 7/5 06/28/22 Sun Country Airlines to replace Neenah in S&P 600 at open on 7/5 06/23/22 Sun Country Airlines offering Buy Now, Pay Later option 02/04/22 Sun Country Airlines issues statement on irregular flight incident NP Neenah $33.77 / -0.37 (-1.08%) 04:55 Today Sun Country Airlines to replace Neenah in S&P 600 at open on 7/5 06/28/22 Sun Country Airlines to replace Neenah in S&P 600 at open on 7/5 03/28/22 Schweitzer-Mauduit and Neenah to merge with $3B in combined revenue 03/07/22 Neenah restarts Brownville, NY facility, affirms FY22 EBITDA of $135M-$145M SWM Schweitzer-Mauduit / + 04:55 Today Sun Country Airlines to replace Neenah in S&P 600 at open on 7/5 06/28/22 Sun Country Airlines to replace Neenah in S&P 600 at open on 7/5 04/28/22 Schweitzer-Mauduit, UbiQD collaborate to develop quantum dot interlayers 03/28/22 Schweitzer-Mauduit and Neenah to merge with $3B in combined revenue SNCY NP SWM SNCY Sun Country Airlines $18.38 / +0.085 (+0.46%) 06/27/22 Evercore ISI Sun Country Airlines price target lowered to $30 from $45 at Evercore ISI 04/07/22 Barclays Sun Country Airlines price target lowered to $32 from $35 at Barclays 02/15/22 Wolfe Research Wolfe upgrades three, downgrades one in U.S. Airlines as new analyst takes over 02/08/22 Deutsche Bank Sun Country Airlines price target lowered to $37 from $46 at Deutsche Bank NP Neenah $33.77 / -0.37 (-1.08%) 07/06/21 Sidoti Neenah upgraded to Buy from Neutral at Sidoti SWM Schweitzer-Mauduit / + SNCY NP SWM SNCY Sun Country Airlines $18.38 / +0.085 (+0.46%) 05/05/22 Sun Country Airlines sees Q2 revenue $210M-$220M, consensus $212.97M 05/05/22 Sun Country Airlines reports Q1 adjusted EPS 20c, consensus 20c 02/07/22 Sun Country Airlines sees Q1 revenue $215M-$225M, consensus $227.48M 02/07/22 Sun Country Airlines reports Q4 EPS 10c, consensus 1c NP Neenah $33.77 / -0.37 (-1.08%) 02/16/22 Neenah reports Q4 EPS 45c, two estimates 53c SWM Schweitzer-Mauduit / + 02/23/22 Schweitzer-Mauduit sees FY22 EPS $2.32-$2.77, consensus $2.16 02/23/22 Schweitzer-Mauduit reports Q4 EPS 36c,one-estimate 28c 15 Oct SNCY SNCY Sun Country Airlines $18.38 / +0.085 (+0.46%) 06/28/22 Fly Intel: After-Hours Movers
Conference/Events	Jefferies technology analyst to hold an analyst/industry conference call » 04:55 07/05/22 07/05 04:55 07/05/22 04:55 HUBS HubSpot $313.62 / +12.78 (+4.25%) Technology Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events HUBS HubSpot $313.62 / +12.78 (+4.25%) 05/11/22 On24 announces availability of engagement, conversion data in HubSpot 03/29/22 HubSpot partners with Pipe to help fund startups 03/22/22 HubSpot appoints Rob Giglio as Chief Customer Officer 02/11/22 HubSpot rises 9.2% HUBS HubSpot $313.62 / +12.78 (+4.25%) 06/09/22 Scotiabank Scotiabank starts 'must-own' HubSpot at Outperform with $550 price target 06/08/22 Scotiabank HubSpot initiated with an Outperform at Scotiabank 05/23/22 Jefferies HubSpot price target lowered to $450 from $500 at Jefferies 05/06/22 BMO Capital HubSpot price target lowered to $405 from $485 at BMO Capital HUBS HubSpot $313.62 / +12.78 (+4.25%) 05/05/22 HubSpot sees FY22 EPS $2.40-$2.42, consensus $2.41 05/05/22 HubSpot sees Q2 EPS 42c44c, consensus 51c 05/05/22 HubSpot reports Q1 EPS 58c, consensus 47c 05/05/22 Notable companies reporting after market close HUBS HubSpot $313.62 / +12.78 (+4.25%) 05/05/22 Fly Intel: After-Hours Movers 04/26/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/18/22 Fly Insider: Sonic Automotive, Moderna among week's notable insider trades 02/11/22 Wall Street in Fives - Must Read Lists for Friday 07/06/22 Technology
Hot Stocks	Stride to replace Omnicell in S&P 600 at open on 7/5 04:55 07/05/22 07/05 04:55 07/05/22 04:55 LRN Stride $41.36 / +0.425 (+1.04%) , OMCL Omnicell $115.30 / +1.62 (+1.43%) ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options LRN OMCL LRN Stride $41.36 / +0.425 (+1.04%) 04:55 Today Stride to replace Omnicell in S&P 600 at open on 7/5 06/29/22 Stride names Donna Blackman as new CFO 06/29/22 Stride rises 10.7% 06/29/22 Stride rises 9.3% OMCL Omnicell $115.30 / +1.62 (+1.43%) 04:55 Today Stride to replace Omnicell in S&P 600 at open on 7/5 04:55 Today Omnicell to replace Coherent in S&P 400 at open on 7/5 06/28/22 Stride to replace Omnicell in S&P 600 at open on 7/5 06/28/22 Omnicell to replace Coherent in S&P 400 at open on 7/5 LRN OMCL LRN Stride $41.36 / +0.425 (+1.04%) 04/21/22 Citi Citi remains buyer of Stride with $65 price target 04/20/22 Barrington Stride price target raised to $50 from $45 at Barrington 09/14/21 Fly Intel: Top five analyst initiations 09/14/21 Citi Stride initiated with a Buy at Citi OMCL Omnicell $115.30 / +1.62 (+1.43%) 06/16/22 Wells Fargo Samsung procurement order halt 'positive' for Omnicell, says Wells Fargo 05/03/22 Wells Fargo Omnicell price target lowered to $158 from $188 at Wells Fargo 05/02/22 Piper Sandler Omnicell price target lowered to $162 from $181 at Piper Sandler 02/16/22 Wells Fargo Omnicell price target lowered to $188 from $203 at Wells Fargo LRN OMCL LRN Stride $41.36 / +0.425 (+1.04%) 04/19/22 Stride raises FY22 revenue view to $1.645B-$1.66B, consensus $1.63B 04/19/22 Stride reports Q3 EPS $1.02, consensus 84c OMCL Omnicell $115.30 / +1.62 (+1.43%) 04/28/22 Omnicell raises FY22 EPS view to $3.85-$4.05 from $3.75-$3.95 04/28/22 Omnicell sees Q2 adjusted EPS 82c-89c, consensus 88c 04/28/22 Omnicell reports Q1 adjusted EPS 83c, consensus 68c 02/14/22 Omnicell sees FY22 adjusted EPS $3.75-$3.95, consensus $4.01 LRN OMCL LRN Stride $41.36 / +0.425 (+1.04%) 06/28/22 Fly Intel: After-Hours Movers 04/19/22 Fly Intel: After-Hours Movers 01/26/22 Wall Street in Fives - Must Read Lists for Wednesday 01/26/22 Wall Street in Fives - Must Read Lists at Midday OMCL Omnicell $115.30 / +1.62 (+1.43%) 02/15/22 Fly Intel: Pre-market Movers 02/14/22 Fly Intel: After-Hours Movers 09/07/22 2022 Wells Fargo Healthcare Conference LRN LRN Stride $41.36 / +0.425 (+1.04%) 01/25/22 K12 options imply 7.9% move in share price post-earnings
Hot Stocks	Omnicell to replace Coherent in S&P 400 at open on 7/5 » 04:55 07/05/22 07/05 04:55 07/05/22 04:55 OMCL Omnicell $115.30 / +1.62 (+1.43%) , COHR Coherent $266.26 / +0.02 (+0.01%) , IIVI II-VI $49.13 / -1.84 (-3.61%) II-VI (IIVI) is acquiring… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events OMCL COHR IIVI OMCL Omnicell $115.30 / +1.62 (+1.43%) 04:55 Today Stride to replace Omnicell in S&P 600 at open on 7/5 04:55 Today Omnicell to replace Coherent in S&P 400 at open on 7/5 06/28/22 Stride to replace Omnicell in S&P 600 at open on 7/5 06/28/22 Omnicell to replace Coherent in S&P 400 at open on 7/5 COHR Coherent $266.26 / +0.02 (+0.01%) 04:55 Today Omnicell to replace Coherent in S&P 400 at open on 7/5 07/01/22 II-VI completes acquisition of Coherent 06/28/22 Omnicell to replace Coherent in S&P 400 at open on 7/5 06/28/22 II-VI obtains all regulatory approvals to complete acquisition of Coherent IIVI II-VI $49.13 / -1.84 (-3.61%) 04:55 Today Omnicell to replace Coherent in S&P 400 at open on 7/5 07/01/22 II-VI completes acquisition of Coherent 06/28/22 Omnicell to replace Coherent in S&P 400 at open on 7/5 06/28/22 II-VI obtains all regulatory approvals to complete acquisition of Coherent OMCL COHR IIVI OMCL Omnicell $115.30 / +1.62 (+1.43%) 06/16/22 Wells Fargo Samsung procurement order halt 'positive' for Omnicell, says Wells Fargo 05/03/22 Wells Fargo Omnicell price target lowered to $158 from $188 at Wells Fargo 05/02/22 Piper Sandler Omnicell price target lowered to $162 from $181 at Piper Sandler 02/16/22 Wells Fargo Omnicell price target lowered to $188 from $203 at Wells Fargo COHR Coherent $266.26 / +0.02 (+0.01%) 03/10/22 Benchmark Coherent, MKS, ASML may be impacted by neon supply from Ukraine, says Benchmark 01/03/22 Raymond James II-VI upgraded to Outperform from Market Perform at Raymond James 12/13/21 Cowen II-VI named a best idea for 2022 at Cowen 11/08/21 Northland NeoPhotonics downgraded to Market Perform from Outperform at Northland IIVI II-VI $49.13 / -1.84 (-3.61%) 07/01/22 Craig-Hallum II-VI price target lowered to $80 from $85 at Craig-Hallum 05/17/22 Piper Sandler Piper moves to 'more positive stance' on semiconductor stocks 05/10/22 Raymond James II-VI price target raised to $82 from $79 at Raymond James 04/14/22 Craig-Hallum II-VI price target lowered to $85 from $100 at Craig-Hallum OMCL COHR IIVI OMCL Omnicell $115.30 / +1.62 (+1.43%) 04/28/22 Omnicell raises FY22 EPS view to $3.85-$4.05 from $3.75-$3.95 04/28/22 Omnicell sees Q2 adjusted EPS 82c-89c, consensus 88c 04/28/22 Omnicell reports Q1 adjusted EPS 83c, consensus 68c 02/14/22 Omnicell sees FY22 adjusted EPS $3.75-$3.95, consensus $4.01 COHR Coherent $266.26 / +0.02 (+0.01%) 05/11/22 Coherent reports Q2 adjusted EPS $1.70, consensus $2.28 02/09/22 Coherent reports Q1 adjusted EPS $2.32, consensus $1.78 IIVI II-VI $49.13 / -1.84 (-3.61%) 05/10/22 II-VI sees Q4 adjusted EPS 85c-$1.00, consensus 92c 05/10/22 II-VI reports Q3 adjusted EPS 95c, consensus 85c 05/09/22 Notable companies reporting before tomorrow's open 05/09/22 Notable companies reporting before tomorrow's open COHR IIVI COHR Coherent $266.26 / +0.02 (+0.01%) 06/23/22 China to conditionally clear II-VI deal to buy Coherent, Dealreporter says 05/18/22 II-VI, Coherent see uncertainty added to SAMR deal reviews, Capitol Forum says IIVI II-VI $49.13 / -1.84 (-3.61%) 06/23/22 China to conditionally clear II-VI deal to buy Coherent, Dealreporter says 05/18/22 II-VI, Coherent see uncertainty added to SAMR deal reviews, Capitol Forum says OMCL COHR IIVI OMCL Omnicell $115.30 / +1.62 (+1.43%) 02/15/22 Fly Intel: Pre-market Movers 02/14/22 Fly Intel: After-Hours Movers COHR Coherent $266.26 / +0.02 (+0.01%) 06/28/22 What You Missed On Wall Street On Tuesday 06/28/22 What You Missed On Wall Street This Morning 05/18/22 What You Missed On Wall Street On Wednesday 05/18/22 What You Missed On Wall Street This Morning IIVI II-VI $49.13 / -1.84 (-3.61%) 06/28/22 What You Missed On Wall Street On Tuesday 06/28/22 What You Missed On Wall Street This Morning 05/18/22 What You Missed On Wall Street On Wednesday 05/18/22 What You Missed On Wall Street This Morning 09/07/22 2022 Wells Fargo Healthcare Conference
Conference/Events	Sanofi to hold an investor event » 04:55 07/05/22 07/05 04:55 07/05/22 04:55 SNY Sanofi $50.91 / +0.95 (+1.90%) ESG Investor Event will… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events SNY Sanofi $50.91 / +0.95 (+1.90%) 07/01/22 Sanofi flu vaccines licensed, approved for 2022-2023 influenza season 07/01/22 Regeneron completes acquisition of Sanofi's stake in Libtayo 06/30/22 Sanofi reports patient enrollment of phase 3 tolebrutinib trials paused in U.S. 06/28/22 Sanofi reports Nexviadyme approved by EC for treatment of Pompe Disease SNY Sanofi $50.91 / +0.95 (+1.90%) 06/07/22 UBS Sanofi price target raised to EUR 119 from EUR 118 at UBS 06/02/22 Piper Sandler Regeneron selloff on Libtayo deal overdone, says Piper Sandler 06/01/22 Wells Fargo Kymera Therapeutics price target lowered to $35 from $62 at Wells Fargo 05/23/22 SVB Leerink Sanofi initiated with an Outperform at SVB Leerink SNY Sanofi $50.91 / +0.95 (+1.90%) 04/28/22 Sanofi still expects 2022 business EPS to grow low double-digit at CER 04/28/22 Sanofi reports Q1 business EPS EUR 1.94, up 16.1% at CER 02/04/22 Sanofi sees 2022 business EPS to grow low double-digit at CER 02/04/22 Sanofi reports Q4 business EPS EUR 1.38, up 9.8% at CER SNY Sanofi $50.91 / +0.95 (+1.90%) 01/29/22 Moderna faces challenges beyond COVID vaccine, stock still a buy, Barron's says 01/05/22 French court permits class action against Sanofi over Depakine, Reuters says SNY Sanofi $50.91 / +0.95 (+1.90%) 06/24/22 What You Missed On Wall Street On Friday 06/24/22 What You Missed On Wall Street This Morning 05/31/22 What You Missed On Wall Street On Tuesday 05/31/22 What You Missed On Wall Street This Morning 00:00 Today 17th International Congress on Neuromuscular Diseases 08:00 Today Sanofi

Events

Earnings calls, analyst events, roadshows and more

SNY
Today at 08:00

Sanofi Firm Sponsored Meetings

Company Headquarters--54, rue La Boetie, Paris
ALNA
Today at 09:00

Allena Pharmaceuticals, Inc. Firm Sponsored Meetings
Today at 10:00

Factory Orders M/M: May 2022 Government Event
PRPO
Today at 10:00

Precipio, Inc. Firm Sponsored Meetings
Today at 11:00

4-Week Bill Announcement Government Event
Today at 11:00

8-Week Bill Announcement Government Event
MIST
Today at 11:00

Milestone Pharmaceuticals Inc. Firm Sponsored Meetings
Today at 11:30

3-Month Bill Auction Government Event
Today at 11:30

6-Month Bill Auction Government Event
TMO ...
Tomorrow at 00:00

16th World Immune Regulation Meeting 2022 Conferences

Davos

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Osisko Development to commence trading on New York Stock Exchange

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access